TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI December 9, 1994
TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination March 29, 2002
TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
